Competing interests
RS
DISEASE, FOUNDER
IDP reports grants from the National Institutes of Health, Centers for Disease Control and Prevention, and Janssen Pharmaceuticals and funding to his institution from Regeneron and Asahi Kasei Pharma. RS reports grants from the National Institutes of Health, the Agency for Healthcare Research, the Centers for Disease Control and Prevention, and the Patient-Centered Research Outcomes Institute. RS is also a physician founder of the IPASS Patient Safety Institute, and his equity is owned by his employer, Intermountain Health. RH reports grants from the National Institutes of Health and consulting (DSMB member) for Pfizer. CKG report grants from the National Institutes of Health. Other authors declare that they have no competing interests.